Acrux Limited (AU:ACR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Phillip Asset Management Ltd, through its BioScience Managers Translation Fund I, has increased its stake in Acrux Limited, now holding 10.32% voting power after a share placement of $200,000. This change, effective from December 19, 2024, highlights the fund’s growing interest in the pharmaceutical company, marking a shift from its previous 15.09% voting power. Investors might consider this move as a signal of potential growth prospects within Acrux Limited.
For further insights into AU:ACR stock, check out TipRanks’ Stock Analysis page.
